This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 Jan;15(1):190-1.

doi: 10.1038/sj.leu.2401952.

CD13/aminopeptidase N involvement in dendritic cell maturation

V H van der Velden, P J Leenen, H A Drexhage

PMID: 11243392
DOI: 10.1038/sj.leu.2401952

CD13/aminopeptidase N involvement in dendritic cell maturation

V H van der Velden et al. Leukemia. 2001 Jan.

. 2001 Jan;15(1):190-1.

doi: 10.1038/sj.leu.2401952.

Authors

V H van der Velden, P J Leenen, H A Drexhage

PMID: 11243392
DOI: 10.1038/sj.leu.2401952

No abstract available

PubMed Disclaimer

Similar articles

CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34(+) cells.
Rosenzwajg M, Tailleux L, Gluckman JC. Rosenzwajg M, et al. Blood. 2000 Jan 15;95(2):453-60. Blood. 2000. PMID: 10627449
Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells.
Dong X, An B, Salvucci Kierstead L, Storkus WJ, Amoscato AA, Salter RD. Dong X, et al. J Immunol. 2000 Jan 1;164(1):129-35. doi: 10.4049/jimmunol.164.1.129. J Immunol. 2000. PMID: 10605003
Human cytomegalovirus induces inhibition of macrophage differentiation by binding to human aminopeptidase N/CD13.
Gredmark S, Britt WB, Xie X, Lindbom L, Söderberg-Nauclér C. Gredmark S, et al. J Immunol. 2004 Oct 15;173(8):4897-907. doi: 10.4049/jimmunol.173.8.4897. J Immunol. 2004. PMID: 15470031
CD13--not just a marker in leukemia typing.
Riemann D, Kehlen A, Langner J. Riemann D, et al. Immunol Today. 1999 Feb;20(2):83-8. doi: 10.1016/s0167-5699(98)01398-x. Immunol Today. 1999. PMID: 10098327 Free PMC article. Review.
Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Wickström M, Larsson R, Nygren P, Gullbo J. Wickström M, et al. Cancer Sci. 2011 Mar;102(3):501-8. doi: 10.1111/j.1349-7006.2010.01826.x. Epub 2011 Jan 30. Cancer Sci. 2011. PMID: 21205077 Free PMC article. Review.

See all similar articles

Cited by

CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells.
Mina-Osorio P, Shapiro LH, Ortega E. Mina-Osorio P, et al. J Leukoc Biol. 2006 Apr;79(4):719-30. doi: 10.1189/jlb.0705425. Epub 2006 Jan 13. J Leukoc Biol. 2006. PMID: 16415167 Free PMC article.
Aminopeptidase N (CD13) is involved in phagocytic processes in human dendritic cells and macrophages.
Villaseñor-Cardoso MI, Frausto-Del-Río DA, Ortega E. Villaseñor-Cardoso MI, et al. Biomed Res Int. 2013;2013:562984. doi: 10.1155/2013/562984. Epub 2013 Aug 26. Biomed Res Int. 2013. PMID: 24063007 Free PMC article.
Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells.
Law HK, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, Nicholls JM, Peiris JS, Lau YL. Law HK, et al. Blood. 2005 Oct 1;106(7):2366-74. doi: 10.1182/blood-2004-10-4166. Epub 2005 Apr 28. Blood. 2005. PMID: 15860669 Free PMC article.

References

1. J Immunol. 1998 Mar 1;160(5):2166-73 - PubMed
1. Blood. 2000 Jan 15;95(2):453-60 - PubMed
1. Eur J Immunol. 1992 Jun;22(6):1567-72 - PubMed
1. Cytokine. 1998 Jan;10(1):55-65 - PubMed
1. J Exp Med. 1994 Apr 1;179(4):1109-18 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Miscellaneous
- NCI CPTAC Assay Portal